Eugenia Quiros-Roldan
Overview
Explore the profile of Eugenia Quiros-Roldan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
177
Citations
6257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gilberti G, Tiecco G, Marconi S, Marullo M, Zanini B, Quiros-Roldan E
Obes Rev
. 2025 Feb;
:e13908.
PMID: 39957406
HIV remains a significant health concern, but the advent of antiretroviral therapy (ART) has transformed it into a manageable chronic condition. However, weight gain and obesity pose a substantial challenge...
2.
Logiudice J, Alberti M, Ciccarone A, Rossi B, Tiecco G, De Francesco M, et al.
Pathogens
. 2025 Jan;
14(1).
PMID: 39861024
The rise and resurgence of vector-borne diseases (VBDs) in Europe pose an expanding public health challenge, exacerbated by climate change, globalization, and ecological disruptions. Both arthropod-borne viruses (arboviruses) transmitted by...
3.
Snyder T, Gittelman R, Klinger M, May D, Osborne E, Taniguchi R, et al.
Front Immunol
. 2025 Jan;
15():1488860.
PMID: 39840037
Introduction: T cells are involved in the early identification and clearance of viral infections and also support the development of antibodies by B cells. This central role for T cells...
4.
Antinori A, Marchetti G, Esposito V, Rusconi S, Canetti D, Quiros-Roldan E, et al.
Int J STD AIDS
. 2025 Jan;
36(4):309-318.
PMID: 39772928
Background: BICSTaR is a multi-national, observational cohort evaluating the effectiveness, safety, and patient-reported outcomes (PROs) in treatment-naïve (TN) and -experienced (TE) people with HIV-1 receiving bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in routine...
5.
Zanella I, Zizioli D, Quiros-Roldan E, Bade A
Front Mol Neurosci
. 2024 Dec;
17:1526357.
PMID: 39660171
No abstract available.
6.
Monforte A, Tavelli A, Quiros-Roldan E, Fabbiani M, Ferrara M, Caputo S, et al.
HIV Med
. 2024 Dec;
26(3):489-499.
PMID: 39618291
Rationale: Doravirine (DOR) is an attractive new option both for ART-naïve people with HIV (PWH) and those with suppressed HIV-RNA who seek treatment simplification. We used real-world data to examine...
7.
Clostridioides difficile infections caused by hypervirulent strains: a single-centre real-life study
Tiecco G, De Francesco M, Lenzi A, Pellizzeri S, Rossini F, Sollima A, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Nov;
44(1):99-107.
PMID: 39527170
Background And Purpose: Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infections worldwide, with hypervirulent strains linked to severe disease and higher mortality. This study aims to analyze...
8.
Pezzaioli L, Porcelli T, Delbarba A, Tiecco G, Castelli F, Cappelli C, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518665
Osteoporosis and vertebral fractures (VFs) are frequently observed in males living with HIV (MLWH). While bisphosphonates seem effective on bone mineral density (BMD) in MLWH, data on VFs are lacking....
9.
Sforza A, Bonito A, Tiecco G, Moioli G, Storti S, Lechiara M, et al.
Microorganisms
. 2024 Oct;
12(10).
PMID: 39458298
Pyelo-hepatic abscess is a rare complication of upper urinary tract infections (UTIs). We describe a case of polymicrobial pyelo-hepatic abscess in an immunocompetent patient. A 71-year-old male patient with a...
10.
Zanini B, Salvi M, Marconi S, Tiecco G, Gilberti G, Castellano M, et al.
BMJ Open
. 2024 Sep;
14(9):e086866.
PMID: 39260867
Introduction: Weight gain, together with the onset of overweight and obesity, is a relevant emerging health issue among people living with HIV (PLWH). A large body of literature recognises this...